VINORELBINE vs VISMODEGIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
VINORELBINE vs VISMODEGIB: Safety Overview
| Metric | VINORELBINE | VISMODEGIB |
|---|---|---|
| Total FAERS Reports | 5,176 | 8,135 |
| Deaths Reported | 840 | 864 |
| Death Rate | 16.2% | 10.6% |
| Hospitalizations | 1,790 | 974 |
| Average Patient Age | 54.8 yrs | 69.6 yrs |
| % Female Patients | 71.8% | 39.3% |
| FDA Approval Date | Apr 18, 2005 | Jan 30, 2012 |
| Manufacturer | Sagent Pharmaceuticals | Genentech, Inc. |
| Route | INTRAVENOUS | ORAL |
| Marketing Status | Discontinued | Prescription |